Sponsor:
Fred Hutchinson Cancer Center
Code:
NCT07052630
Conditions
Hematopoietic and Lymphatic System Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Internet-Based Intervention
Patient Navigation
Best Practice
Survey Administration
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Study ID
NCT07052630
Start date
Oct 21, 2025
Status verified date
Jun, 2026
Completion date
Oct 31, 2026
Anticipated
Primary completion date
Sep 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
40 participants
Anticipated
Allocation
Randomized
Intervention Model
Factorial
Primary purpose
Supportive Care
Arms
experimental: Condition 1 (PACT, patient navigation)
experimental: Condition 2 (patient navigation)
experimental: Condition 3 (PACT)
active comparator: Condition 4 (standard/usual care)
Interventions
Internet-Based Intervention
Patient Navigation
Best Practice
Survey Administration
Primary outcome measure
Central contacts
Locations
Fred Hutch/University of Washington Cancer Consortium
Recruiting
Seattle, Washington, United States, 98109
Contacts
Principal Investigator:
Megan Shen, PhD
Sponsor
Fred Hutchinson Cancer Center
Last update posted
Jun 5, 2026
Last verified
Jun, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Fred Hutchinson Cancer Center on 2026-06-05.